United States· US:0069-0188_fb858b80-8bd4-43a6-8871-9819a35ca03f
Ibrance
A medicinal product containing palbociclib, registered in United States by Pfizer Laboratories Div Pfizer Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- palbociclib
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11006901882121 CAPSULE in 1 BOTTLE (0069-0188-21)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Palbociclib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIBRANCEPfizer Europe MA EEIG, Bruxelles
- SpainIBRANCE 100 MG CAPSULAS DURASPfizer Europe Ma Eeig
- United KingdomIbrance 100mg capsulesPfizer Ltd
- FinlandIBRANCEPfizer Europe MA EEIG
- FranceIBRANCE 100 mg, gélulePFIZER EUROPE MA EEIG (BELGIQUE)
- BelgiumIbrance 100 mgPfizer Europe MA
- IrelandIBRANCE 100 mg hard capsulesPfizer Europe MA EEIG
- IcelandIbrancePfizer Europe MA EEIG*
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Ibrammaclib
- Bulgaria · Palbociclib
- Denmark · Palbociclib Newbury
- Estonia · Palbociclib
- Finland · Palbociclib Avansor
- United Kingdom (Northern Ireland) · Palbociclib Thornton & Ross
- Greece · Palbociclib Faran
- Croatia · Palbociclib
- Hungary · Palbociclib
- Iceland · Ibrance, Palbociclib Viatris
- Liechtenstein · Ibrance, Palbociclib Viatris
- Malta · Palbociclib, Palbociclib Lotus
- Netherlands · Ibaclib, Palbociclib Elpen
- Norway · Ibrance, Palbociclib Newbury
- Poland · Palbociclib Polpharma
- Sweden · Brancen, Brical
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b51eb0a-fad7-464e-9368-acf036d8b754 GET /v1/drugs/6b51eb0a-fad7-464e-9368-acf036d8b754?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 3
},
"productid": "0069-0188_fb858b80-8bd4-43a6-8871-9819a35ca03f",
"productndc": "0069-0188",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "PALBOCICLIB",
"proprietary_name": "Ibrance",
"active_ingred_unit": "mg/1",
"application_number": "NDA207103",
"marketing_category": "NDA",
"nonproprietary_name": "palbociclib",
"start_marketing_date": "20150203",
"active_numerator_strength": "100"
}See everything about palbociclib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.